World's Best Scientists 2026 revealed!
Michel D. Kazatchkine

Michel D. Kazatchkine

D-Index & Metrics

Immunology

D-Index
105
Citations
35164
World Ranking
601
National Ranking
17

Medicine

D-Index
105
Citations
35262
World Ranking
6834
National Ranking
204

Michel D. Kazatchkine publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michel D. Kazatchkine sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 528 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michel D. Kazatchkine D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michel D. Kazatchkine sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 105 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michel D. Kazatchkine is affiliated with Université Paris Cité in France and has contributed extensively to the field of medicine, particularly focusing on infectious diseases and public health. Their research encompasses a broad spectrum within medicine, with notable emphasis on infectious diseases, general health professions, epidemiology, public health, environmental and occupational health, and modeling and simulation.

The scientist's work addresses key topics such as COVID-19 epidemiological studies, SARS-CoV-2 and COVID-19 research, HIV, drug use and sexual risk, vaccine coverage and hesitancy, global public health policies and epidemiology, COVID-19 clinical research studies, and global health care issues.

Among recent significant papers are:

  • Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights, 2021, The Lancet
  • It is time for ambitious, transformational change to the epidemic countermeasures ecosystem, 2023, The Lancet
  • From private incentives to public health need: rethinking research and development for pandemic preparedness, 2023, The Lancet Global Health
  • Transforming or tinkering: the world remains unprepared for the next pandemic threat, 2022, The Lancet
  • Stopping epidemics when and where they occur, 2023, The Lancet

Collaboration has been an integral part of their research, frequently working with co-authors such as Joanne Liu, Helen Clark, Helena Legido-Quigley, Martin McKee, and Els Torreele.

Michel D. Kazatchkine has published predominantly in venues like The Lancet, BMJ, Harm Reduction Journal, The Lancet Global Health, and The Lancet Psychiatry. The most frequent publication venue is The Lancet, with eleven papers, followed by BMJ and Harm Reduction Journal.

Best Publications

  • Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.

    Michel D. Kazatchkine;Srini V. Kaveri

  • Cutting Edge: Human CD4+CD25+ T Cells Restrain the Maturation and Antigen-Presenting Function of Dendritic Cells

    Namita Misra;Jagadeesh Bayry;Sébastien Lacroix-Desmazes;Michel D. Kazatchkine

  • ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN

    Y. Sultan;Y. Sultan;P. Maisonneuve;P. Maisonneuve;M.D. Kazatchkine;M.D. Kazatchkine;U.E. Nydegger;U.E. Nydegger

  • Public health and international drug policy

    Joanne Csete;Adeeba Kamarulzaman;Michel Kazatchkine;Frederick Altice

  • Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.

    Sophie Grabar;Vincent Le Moing;Cécile Goujard;Catherine Leport

  • Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission

    Linda Gail Bekker;Linda Gail Bekker;George Alleyne;Stefan Baral;Javier Cepeda

  • Natural autoantibodies

    Unknown

  • Self-reactive antibodies (natural autoantibodies) in healthy individuals

    Sébastien Lacroix-Desmazes;Srini V Kaveri;Luc Mouthon;Ahidjo Ayouba

  • Therapeutic Preparations of Normal Polyspecific IgG (IVIg) Induce Apoptosis in Human Lymphocytes and Monocytes: A Novel Mechanism of Action of IVIg Involving the Fas Apoptotic Pathway

    Nagendra K. A. Prasad;Giuliana Papoff;Ann Zeuner;Emmanuelle Bonnin

  • Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin

    Jagadeesh Bayry;Sébastien Lacroix-Desmazes;Cedric Carbonneil;Namita Misra

  • High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse.

    Christophe Piketty;Teresa M. Darragh;Maria Da Costa;Patrick Bruneval

  • Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.

    Amal Ephrem;Souleima Chamat;Catherine Miquel;Sylvain Fisson;Sylvain Fisson;Sylvain Fisson

  • Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action

    Vir-Singh Negi;Sriramulu Elluru;Sophie Sibéril;Stéphanie Graff-Dubois

  • Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

    Christian Laurent;Charles Kouanfack;Sinata Koulla-Shiro;Nathalie Nkoué

  • Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes.

    E Fischer;C Delibrias;M D Kazatchkine

  • A call to action for comprehensive HIV services for men who have sex with men

    Chris Beyrer;Patrick S Sullivan;Jorge Sanchez;David Dowdy

  • DISCREPANT RESPONSES TO TRIPLE COMBINATION ANTIRETROVIRAL THERAPY IN ADVANCED HIV DISEASE

    Piketty C;Castiel P;Belec L;Batisse D

  • The need for a global HIV vaccine enterprise

    Richard D. Klausner;Anthony S. Fauci;Lawrence Corey;Lawrence Corey;Gary J. Nabel

  • An action agenda for HIV and sex workers

    Chris Beyrer;Anna Louise Crago;Linda Gail Bekker;Jenny Butler

  • Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.

    Isabelle Heard;Valérie Schmitz;Dominique Costagliola;Gérard Orth

  • Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass.

    Nicole Haeffner-Cavaillon;Nicole Roussellier;Olivier Ponzio;Marie-Paule Carreno

Frequent Co-Authors

Srini V. Kaveri
Srini V. Kaveri Centre national de la recherche scientifique, CNRS
Sébastien Lacroix-Desmazes
Sébastien Lacroix-Desmazes Sorbonne University
Jagadeesh Bayry
Jagadeesh Bayry Indian Institute of Technology Palakkad
Laurence Weiss
Laurence Weiss Université Paris Cité
Laurent Bélec
Laurent Bélec Université Paris Cité
Nicole Haeffner-Cavaillon
Nicole Haeffner-Cavaillon Inserm : Institut national de la santé et de la recherche médicale
Nicolas Chomont
Nicolas Chomont University of Montreal
Luc Mouthon
Luc Mouthon Université Paris Cité
Patrick Bruneval
Patrick Bruneval Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Many students consider accelerated nursing programs, especially if they come from a non-nursing background. Programs like accelerated bsn programs for non nurses offer a fast track to becoming a registered nurse, making it an excellent stepping stone into clinical immunology roles.

Starting with a Licensed Practical Nurse credential is another viable option. Understanding which lpn programs are easiest to get into can help prospective students find programs that balance accessibility with quality training.

For advanced practice, pursuing a Family Nurse Practitioner degree is a popular choice. Those searching for flexible education often look at the easiest fnp program, combining manageable admission requirements with comprehensive clinical training.

Additionally, specialized programs like the best psychiatric mental health nurse practitioner programs online prepare students for roles in mental health, a field closely linked with immunological research and patient care. Exploring these programs can broaden career options and enhance your expertise in health sciences.

Best Scientists Citing Michel D. Kazatchkine

Trending Scientists

Recently Published Articles